Latest filing published 23 Jan 2026 for Acumen Pharmaceuticals, Inc., €3,811.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Matt Zuga: trading record in brief
Filings by Matt Zuga span 2 companies, the busiest being Acumen Pharmaceuticals, Inc. and TELA Bio, Inc. Over a trading history stretching from 8 November 2019 to 22 January 2026, the count stands at 23 filings.
Market trades split into 2 purchases (€1.0M) and 11 sales (€135k). The net balance comes to €881k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 4 share grants and 1 option exercise. Since January 2026: no purchases and 7 sales on the market.
The newest entry dates from 23 January 2026: an open-market sale of €2,688, in Acumen Pharmaceuticals, Inc. The last insider purchase was made public on 13 November 2019, 2,553 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matt Zuga
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,473 shares@ US$1.80723.1% of flowCommon StockSEC:0001628280-26-003347:0
- 99,133 shares0Common StockSEC:0001628280-26-002961:0
- 6,888 shares@ US$1.81668.8% of flowCommon StockSEC:0001628280-26-001898:0
- 4,000 shares@ US$1.96065.5% of flowCommon StockSEC:0001628280-26-001265:0
- 4,364 shares@ US$1.60096.6% of flowCommon StockSEC:0001576885-25-000037:0
- 13,235 shares@ US$1.841123.5% of flowCommon StockSEC:0001576885-25-000011:0
- 66,800 shares0Common StockSEC:0001576885-25-000011:1
- 4,242 shares@ US$3.70514.3% of flowCommon StockSEC:0001576885-24-000026:0
- 106,000 shares0Common StockSEC:0001576885-24-000010:0
- 33,500 shares0Common StockSEC:0001209191-23-003750:0
- 50,000 shares@ US$1.1955.5% of flowCommon StockSEC:0001209191-23-000327:0
- 26,187 sharesCommon StockSEC:0001209191-21-046031:0
12 of 12 declarations
